Business Context and Reporting Period
This Form 6-K filing by GSK plc is a transaction notification dated August 1, 2024. The report discloses the company's issued share capital and total voting rights as of July 31, 2024, in conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on capital structure metrics:
- Issued Share Capital: 4,314,229,164 Ordinary Shares of 31.25 pence each.
- Treasury Shares: 169,171,155 Ordinary Shares held in Treasury.
- Total Voting Rights: 4,145,058,009.
Material Changes
The filing text does not provide comparative data for prior periods or explicitly state material changes in share capital or voting rights versus previous reporting dates.
Guidance, Outlook, and Risks
The document contains no management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items. Its sole purpose is to notify the market of the denominator for shareholder interest calculations under FCA rules.
Investor Verification Checklist
- Verify the total number of voting rights (4,145,058,009) for compliance with FCA disclosure thresholds.
- Confirm the number of shares held in Treasury (169,171,155) to calculate the free float accurately.
- Check the share price and total market capitalization using the issued share count of 4,314,229,164.